Home
/
SANUWAVE Health, Inc.
/
Financials
/
Quarterly
SANUWAVE Health, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that SANUWAVE Health, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$11.45M
Nov 6, 2025
Q2
2025
Jun 30, 2025
$10.16M
Aug 7, 2025
Q1
2025
Mar 31, 2025
$9.34M
May 8, 2025
Q3
2025
Sep 30, 2024
$9.36M
Nov 6, 2025
Q2
2025
Jun 30, 2024
$7.16M
Aug 7, 2025
Q1
2025
Mar 31, 2024
$5.79M
May 8, 2025
Q3
2024
Sep 30, 2023
$4.95M
Nov 7, 2024
Q2
2024
Jun 30, 2023
$4.68M
Aug 12, 2024
Q1
2024
Mar 31, 2023
$3.78M
May 9, 2024
Q3
2023
Sep 30, 2022
$4.17M
Nov 9, 2023
Q2
2023
Jun 30, 2022
$3.88M
Aug 10, 2023
Q1
2023
Mar 31, 2022
$3.20M
May 11, 2023
Q3
2022
Sep 30, 2021
$3.73M
Nov 14, 2022
Q2
2022
Jun 30, 2021
$2.91M
Aug 12, 2022
Q1
2022
Mar 31, 2021
$2.12M
May 26, 2022
Q3
2020
Sep 30, 2020
$1.97M
Jul 1, 2021
Q2
2020
Jun 30, 2020
$83.3K
Aug 14, 2020
Q1
2020
Mar 31, 2020
$148.6K
May 15, 2020
Q3
2020
Sep 30, 2019
$197.6K
Jul 1, 2021
Q2
2020
Jun 30, 2019
$317.0K
Aug 14, 2020
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$11.42M
Nov 6, 2025
Q2
2025
Jun 30, 2025
$10.15M
Aug 7, 2025
Q1
2025
Mar 31, 2025
$9.29M
May 8, 2025
Q3
2025
Sep 30, 2024
$9.29M
Nov 6, 2025
Q2
2025
Jun 30, 2024
$7.08M
Aug 7, 2025
Q1
2025
Mar 31, 2024
$5.68M
May 8, 2025
Q3
2024
Sep 30, 2023
$4.82M
Nov 7, 2024
Q2
2024
Jun 30, 2023
$4.41M
Aug 12, 2024
Q1
2024
Mar 31, 2023
$3.49M
May 9, 2024
Q3
2023
Sep 30, 2022
$3.92M
Nov 9, 2023
Q2
2023
Jun 30, 2022
$3.54M
Aug 10, 2023
Q1
2023
Mar 31, 2022
$2.85M
May 11, 2023
Q3
2021
Sep 30, 2021
$3.73M
Feb 28, 2022
Q2
2022
Jun 30, 2021
$2.63M
Aug 12, 2022
Q1
2022
Mar 31, 2021
$1.86M
May 26, 2022
Q3
2021
Sep 30, 2020
$1.37M
Feb 28, 2022
Q2
2021
Jun 30, 2020
$83.0K
Jan 14, 2022
Q1
2021
Mar 31, 2020
$149.0K
Dec 13, 2021
Q3
2020
Sep 30, 2019
$197.6K
Jul 1, 2021
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$10.33M
Nov 6, 2025
Q2
2025
Jun 30, 2025
$1.06M
Aug 7, 2025
Q1
2025
Mar 31, 2025
($5.68M)
May 8, 2025
Q3
2025
Sep 30, 2024
($20.66M)
Nov 6, 2025
Q2
2025
Jun 30, 2024
$6.56M
Aug 7, 2025
Q1
2025
Mar 31, 2024
($4.53M)
May 8, 2025
Q3
2024
Sep 30, 2023
($23.70M)
Nov 7, 2024
Q2
2024
Jun 30, 2023
($7.26M)
Aug 12, 2024
Q1
2024
Mar 31, 2023
($13.08M)
May 9, 2024
Q3
2023
Sep 30, 2022
($1.14M)
Nov 9, 2023
Q2
2023
Jun 30, 2022
$1.64M
Aug 10, 2023
Q1
2023
Mar 31, 2022
($5.10M)
May 11, 2023
Q3
2022
Sep 30, 2021
($4.25M)
Nov 14, 2022
Q2
2022
Jun 30, 2021
($8.62M)
Aug 12, 2022
Q1
2022
Mar 31, 2021
($4.94M)
May 26, 2022
Q3
2021
Sep 30, 2020
($12.64M)
Feb 28, 2022
Q2
2021
Jun 30, 2020
($3.63M)
Jan 14, 2022
Q1
2021
Mar 31, 2020
($3.00M)
Dec 13, 2021
Q3
2020
Sep 30, 2019
($2.75M)
Jul 1, 2021
Q2
2020
Jun 30, 2019
($2.73M)
Aug 14, 2020
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$1.47M
Nov 6, 2025
Q2
2025
Jun 30, 2025
$1.88M
Aug 7, 2025
Q1
2025
Mar 31, 2025
$986.0K
May 8, 2025
Q3
2025
Sep 30, 2024
$1.95M
Nov 6, 2025
Q2
2025
Jun 30, 2024
$1.99M
Aug 7, 2025
Q1
2025
Mar 31, 2024
($1.05M)
May 8, 2025
Q3
2024
Sep 30, 2023
($531.0K)
Nov 7, 2024
Q2
2024
Jun 30, 2023
$931.0K
Aug 12, 2024
Q1
2024
Mar 31, 2023
($1.98M)
May 9, 2024
Q3
2023
Sep 30, 2022
($2.49M)
Nov 9, 2023
Q2
2023
Jun 30, 2022
($3.05M)
Aug 10, 2023
Q1
2023
Mar 31, 2022
($1.96M)
May 11, 2023
Q3
2022
Sep 30, 2021
($3.34M)
Nov 14, 2022
Q2
2022
Jun 30, 2021
($4.05M)
Aug 12, 2022
Q1
2022
Mar 31, 2021
($4.39M)
May 26, 2022
Q3
2021
Sep 30, 2020
($6.37M)
Feb 28, 2022
Q2
2021
Jun 30, 2020
($3.27M)
Jan 14, 2022
Q1
2021
Mar 31, 2020
($2.80M)
Dec 13, 2021
Q3
2020
Sep 30, 2019
($2.39M)
Jul 1, 2021
Q2
2020
Jun 30, 2019
($2.02M)
Aug 14, 2020